Inventor · disambiguated record
Bin Ye
Also filed as: YE BIN
26 granted patents·13 pending applications·473 citations·filing 1995–2024
96Inventor score
Top patents by PatentIndex Score
39 records- 0196US6140351AOrtho-anthranilamide derivatives as anti-coagulantsBERLEX LAB·Filed 1998·Granted Oct 31, 2000·179 cites·50 claims
- 0294US6432947B1N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 1999·Granted Aug 13, 2002·89 cites·34 claims
- 0392US9315509B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseCELTAXSYS INC·Filed 2014·Granted Apr 19, 2016·17 cites·20 claims
- 0492US7737145B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseESTRELLITA PHARMACEUTICALS LLC·Filed 2006·Granted Jun 15, 2010·32 cites·10 claims
- 0591US6380221B1Ortho-anthranilamide derivatives as anti-coagulantsBERLEX LAB·Filed 2000·Granted Apr 30, 2002·33 cites·5 claims
- 0690US11267819B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseCELLTAXIS LLC·Filed 2020·Granted Mar 8, 2022·2 cites·21 claims
- 0790US9562060B2Heterocyclic pyridone compound, and intermediate, preparation method and use thereofCHENG JIANJUN·Filed 2012·Granted Feb 7, 2017·13 cites·10 claims
- 0890US8569303B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseARNAIZ DAMIAN O·Filed 2010·Granted Oct 29, 2013·19 cites·12 claims
- 0988US2025296935A1Diamine Derivatives as Inhibitors of Leukotriene A4 HydrolaseCELLTAXIS LLC·Filed 2024·Application pending·0 cites
- 1083US6498185B1Ortho-anthranilamide derivatives as anti-coagulantsBERLEX LAB·Filed 2000·Granted Dec 24, 2002·14 cites·17 claims
- 1182US7220856B2Substituted quinoline CCR5 receptor antagonistsSCHERING AG·Filed 2003·Granted May 22, 2007·22 cites·8 claims
- 1281US12173009B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseCELLTAXIS LLC·Filed 2022·Granted Dec 24, 2024·0 cites·23 claims
- 1378US6747031B2N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 2002·Granted Jun 8, 2004·6 cites·10 claims
- 1473US6670473B2N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 2002·Granted Dec 30, 2003·3 cites·8 claims
- 1571US7112408B2Detection of ovarian cancer based upon alpha-haptoglobin levelsBRIGHAM & WOMENS HOSPITAL·Filed 2002·Granted Sep 26, 2006·14 cites·18 claims
- 1670US6841674B2N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 2002·Granted Jan 11, 2005·2 cites·6 claims
- 1767US8198456B2Dihydropyridine derivatives as useful as protein kinase inhibitorsADLER MARC·Filed 2007·Granted Jun 12, 2012·2 cites·10 claims
- 1866US7485455B2Nucleic acid encoding sodium channel subunitWISCONSIN ALUMNI RES FOUND·Filed 2003·Granted Feb 3, 2009·2 cites·6 claims
- 1966US6887865B2N-heterocyclic derivatives as NOS inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2002·Granted May 3, 2005·1 cites·8 claims
- 2066US6849739B2N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 2002·Granted Feb 1, 2005·1 cites·2 claims
- 2166US6846829B2N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 2002·Granted Jan 25, 2005·1 cites·18 claims
- 2265US2018230159A1Diamine derivatives as inhibitors of leukotriene a4 hydrolaseCELTAXSYS INC·Filed 2018·Application pending·0 cites
- 2363US7288383B2Eosinophil-derived neurotoxin as a marker for ovarian cancerBRIGHAM & WOMENS HOSPITAL·Filed 2004·Granted Oct 30, 2007·6 cites·5 claims
- 2463US2024150855A1Methods and compositions for identifying viral sequencesDECODE CURE LTD·Filed 2023·Application pending·0 cites
- 2561US2013123243A1Diamine derivatives as inhibitors of leukotriene a4 hydrolaseCELTAXSYS INC·Filed 2012·Application pending·0 cites
- 2660US2016272649A1Diamine derivatives as inhibitors of leukotriene a4 hydrolaseCELTAXSYS INC·Filed 2016·Application pending·0 cites
- 2757US8642347B2Urinary CA125 peptides as biomarkers of ovarian cancerYE BIN·Filed 2009·Granted Feb 4, 2014·1 cites·20 claims
- 2857US2025101011A1Peptidyl nitrile compound and use thereofSHANGHAI YIDIAN PHARMACEUTICAL TECH DEVELOPMENT CO LTD·Filed 2023·Application pending·0 cites
- 2955US6864263B2N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 2002·Granted Mar 8, 2005·0 cites·11 claims
- 3055US6841673B2N-heterocyclic derivatives as nos inhibitorsBERLEX LAB·Filed 2002·Granted Jan 11, 2005·0 cites·1 claims
- 3153US2009099102A1Ginkgolides in the Treatment and Prevention of Ovarian CancerBRIGHAM & WOMENS HOSPITAL·Filed 2006·Application pending·0 cites
- 3252US5688992AO-malonyltryrosyl compounds, O-malonyltryrosyl compound-containing peptides, and use thereofUS HEALTH·Filed 1995·Granted Nov 18, 1997·14 cites·11 claims
- 3349US6864368B2N-heterocyclic derivatives as NOS inhibitorsBERLAX LAB INC·Filed 2002·Granted Mar 8, 2005·0 cites·1 claims
- 3445US2005101644A1Benzylether amine compounds useful as CCR-5 antagonistsSCHERING AG·Filed 2004·Application pending·0 cites
- 3544US2005009120A1Methods of detecting ovarian cancer based on osteopontinBRIGHAM & WOMENS HOSPITAL·Filed 2004·Application pending·0 cites
- 3642US2007155727A1Amide inhibitors of leukotriene A4 hydrolaseSCHERING AKTIENGESSELLSCHAFT·Filed 2006·Application pending·0 cites
- 3742US2005020605A1Quinolyl amide derivatives as CCR-5 antagonistsSCHERING AG·Filed 2004·Application pending·0 cites
- 3838US2008293087A1Sulfonylurea receptor short forms from mitochondria and uses thereofMAKIELSKI JONATHAN C·Filed 2007·Application pending·0 cites
- 3935US2003157600A1Sodium channel alpha subunitsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bin Ye files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →